Oramed’s Oravax Oral COVID-19 Vaccine to Begin Phase 1 Clinical Trial
Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed,com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that its majority-owned subsidiary, Oravax Medical Inc., has…
Continue Reading
Oramed’s Oravax Oral COVID-19 Vaccine to Begin Phase 1 Clinical Trial